Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04055571 · ClinicalTrials.gov registry record
Evaluation of Outcomes From Treatment of Benign or Malignant Pancreatic Diseases
A clinical trial of Benign or Malignant Pancreatic Diseases, sponsored by Methodist Health System.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT04055571: Recruiting study of Benign or Malignant Pancreatic Diseases, sponsored by Methodist Health System.
NCT04055571 is a study of Benign or Malignant Pancreatic Diseases that is actively recruiting participants, run by Methodist Health System. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04055571, a study of Benign or Malignant Pancreatic Diseases, is actively recruiting participants, sponsored by Methodist Health System.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will be a retrospective chart review of patients who have been diagnosed with the benign or malignant pancreatic disease under the practice of Dr. Rohan Jeyarajah, M.D., Dr. Houssam Osman M.D., and Dr. Edward Cho M.D., Sc.M. at Methodist Health System Hospital in Richardson, TX. The investigators plan to conduct an analysis of patients meeting the inclusion criteria from 2005 to present. Study will also be conducted by the PI, Sub-Is, surgery fellows, office staff and clinical research coordinator who are delegated to do by the PI. Data will be obtained by looking through either investigator's patients or through a national database. Data will be analyzed primarily by the study conductors.
Primary Outcome
Number of patients who have been diagnosed with benign or malignant pancreatic disease
Conditions Studied
Study Locations (1)
Texas
- Trinity Surgical Consultants, Methodist Richardson Medical Center - Richardson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2019-03-05 |
| Est. Completion | 2025-01-30 |
What NCT04055571 shows while recruiting
NCT04055571 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Benign or Malignant Pancreatic Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT04055571 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04055571 about?
NCT04055571 is a clinical study titled "Evaluation of Outcomes From Treatment of Benign or Malignant Pancreatic Diseases". This study will be a retrospective chart review of patients who have been diagnosed with the benign or malignant pancreatic disease under the practice of Dr. Rohan Jeyarajah, M.D., Dr. Houssam Osman M.D., and Dr. Edward Cho M.D., Sc.M. at Methodist Health System Hospital in Richardson, TX. The inves...
What is the current status of trial NCT04055571?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2019-03-05. Estimated completion is 2025-01-30.
What conditions does trial NCT04055571 study?
This clinical trial studies the following conditions: Benign or Malignant Pancreatic Diseases.
Who is sponsoring clinical trial NCT04055571?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04055571 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI